Literature DB >> 18254519

Complementary and alternative medicine use in rheumatoid arthritis: an audit of patients visiting a tertiary care centre.

Tarique Zaman1, Shikhar Agarwal, Rohini Handa.   

Abstract

BACKGROUND: Complementary and alternative medicine (CAM) enjoys widespread popularity in chronic illnesses such as rheumatic diseases. Rheumatoid arthritis (RA) is the commonest inflammatory joint disease seen in clinical practice. No systematic study on the use of CAM by patients with RA is available from northern India.
METHODS: We evaluated the prevalence and usage characteristics of CAM in Indian patients with RA using a questionnaire at a tertiary care centre in northern India.
RESULTS: Of the 102 patients with RA included in the study, 39% reported current CAM use. As many as 84 respondents (82%) reported having tried CAM during the course of their disease. A total of 215 CAM courses were used, out of which 77 were being continued. Ayurveda was the commonest (28% courses) followed by homoeopathy (20%), yoga asana (17%) and pranayama (12%). Pain control was the primary reason for using CAM (69% of users). Most CAM therapies (78%) were started on the advice of friends and relatives. Discontinuation of CAM was attributed to lack of clinical benefit (78%) and adverse effects (10%). Of the patients using CAM, 87% did not reveal its use to their physicians, primarily because the physician did not enquire about it.
CONCLUSION: Patients with RA frequently use CAM for pain control. These practices are often not revealed to the treating physician. Knowledge of the concurrent use of CAM may serve to alert the physician about potential side-effects or drug interactions.

Entities:  

Mesh:

Year:  2007        PMID: 18254519

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  11 in total

Review 1.  Rheumatology in India--quo vadis?

Authors:  Rohini Handa
Journal:  Nat Rev Rheumatol       Date:  2014-11-04       Impact factor: 20.543

Review 2.  The clinical spectrum of juvenile idiopathic arthritis in a large urban population.

Authors:  Melissa S Tesher; Karen B Onel
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 3.  Herbal medicine for rheumatic diseases: promises kept?

Authors:  Sharon L Kolasinski
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

4.  Use of Indian (Ayurveda) style alternative medicine in Thailand.

Authors:  Viroj Wiwanitkit
Journal:  Int J Ayurveda Res       Date:  2010-10

Review 5.  The Efficacy of Tai Chi and Yoga in Rheumatoid Arthritis and Spondyloarthropathies: A narrative biomedical review.

Authors:  Gulseren Akyuz; Ozge Kenis-Coskun
Journal:  Rheumatol Int       Date:  2017-11-04       Impact factor: 2.631

Review 6.  Use of Complementary and Alternative Medicine among Osteoarthritic Patients: A Review.

Authors:  Muhammad Umair Khan; Shazia Qasim Jamshed; Akram Ahmad; Mohd Ashraf Bin Ahmad Bidin; Mohammad Jamshed Siddiqui; Abdul Kareem Al-Shami
Journal:  J Clin Diagn Res       Date:  2016-02-01

7.  Perception, attitude and usage of complementary and alternative medicine among doctors and patients in a tertiary care hospital in India.

Authors:  Vandana Roy; Monica Gupta; Raktim Kumar Ghosh
Journal:  Indian J Pharmacol       Date:  2015 Mar-Apr       Impact factor: 1.200

8.  Adrenal suppression following herbal remedy for rheumatoid arthritis.

Authors:  Balasekar Premkumar; Muppavarapu Srinivasa Murthy; Karuppasamy Rajagopal; Vadivelmurugan Nagasubramani Nagaprabu; Sree Madhuri Ponugupati
Journal:  J Pharmacol Pharmacother       Date:  2015 Apr-Jun

9.  Role of DMARD Naïve Period in the Development of Severe Rheumatoid Arthritis.

Authors:  Madhav Bahadur; Paramjeet Singh; Vivekanand Satyawali; Arun Joshi
Journal:  Indian J Orthop       Date:  2020-03-10       Impact factor: 1.251

10.  A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference.

Authors:  Harald J Hamre; Van N Pham; Christian Kern; Rolf Rau; Jörn Klasen; Ute Schendel; Lars Gerlach; Attyla Drabik; Ludger Simon
Journal:  Patient Prefer Adherence       Date:  2018-03-16       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.